277 related articles for article (PubMed ID: 29605800)
21. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
[TBL] [Abstract][Full Text] [Related]
22. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
Yazdani S; Jadidfard MP
Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
[TBL] [Abstract][Full Text] [Related]
23. Health technology assessment in middle-income countries: recommendations for a balanced assessment system.
Dankó D
J Mark Access Health Policy; 2014; 2():. PubMed ID: 27226832
[TBL] [Abstract][Full Text] [Related]
24. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
Mühlbacher AC; Kaczynski A
Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
[TBL] [Abstract][Full Text] [Related]
25. Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.
Angelis A; Lange A; Kanavos P
Eur J Health Econ; 2018 Jan; 19(1):123-152. PubMed ID: 28303438
[TBL] [Abstract][Full Text] [Related]
26. IS THE EUNETHTA HTA CORE MODEL® FIT FOR PURPOSE? EVALUATION FROM AN INDUSTRY PERSPECTIVE.
Gyldmark M; Lampe K; Ruof J; Pöhlmann J; Hebborn A; Kristensen FB
Int J Technol Assess Health Care; 2018 Jan; 34(5):458-463. PubMed ID: 30334508
[TBL] [Abstract][Full Text] [Related]
27. A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND.
Lipska I; McAuslane N; Leufkens H; Hövels A
Int J Technol Assess Health Care; 2017 Jan; 33(3):350-357. PubMed ID: 28720170
[TBL] [Abstract][Full Text] [Related]
28. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
29. How can multi criteria decision analysis support value assessment of pharmaceuticals? - Findings from a systematic literature review.
Kolasa K; Zah V; Kowalczyk M
Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):379-391. PubMed ID: 29707985
[TBL] [Abstract][Full Text] [Related]
30. [Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies].
Castillo-Laborde C; Silva-Illanes N
Rev Med Chil; 2014 Jan; 142 Suppl 1():S33-8. PubMed ID: 24861178
[TBL] [Abstract][Full Text] [Related]
31. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
[TBL] [Abstract][Full Text] [Related]
32. Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.
Angelis A; Thursz M; Ratziu V; O'Brien A; Serfaty L; Canbay A; Schiefke I; Costa JBE; Lecomte P; Kanavos P
Med Decis Making; 2020 Aug; 40(6):830-845. PubMed ID: 32845234
[No Abstract] [Full Text] [Related]
33. HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status.
Rosselli D; Quirland-Lazo C; Csanádi M; Ruiz de Castilla EM; González NC; Valdés J; Abicalaffe C; Garzón W; Leon G; Kaló Z
Value Health Reg Issues; 2017 Dec; 14():20-27. PubMed ID: 29254537
[TBL] [Abstract][Full Text] [Related]
34. Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.
Wong CKH; Wu O; Cheung BMY
Appl Health Econ Health Policy; 2018 Feb; 16(1):5-14. PubMed ID: 28702874
[TBL] [Abstract][Full Text] [Related]
35. DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT.
Krahn M; Miller F; Bayoumi A; Brooker AS; Wagner F; Winsor S; Giacomini M; Goeree R; Schünemann H; van der Velde G; Petersen S; Sikich N; Dhalla I
Int J Technol Assess Health Care; 2018 Jun; 34(3):290-299. PubMed ID: 29987995
[TBL] [Abstract][Full Text] [Related]
36. [Study on establishing a methodology of comprehensive clinical evaluation for Chinese patent medicine based on health technology assessment].
Liao X; Guo WD; Cao Z; Xu HY; Zhang YL; Zhao H; Wang YY
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(16):3749-3758. PubMed ID: 32893567
[TBL] [Abstract][Full Text] [Related]
37. Improving Hospital Based Medical Procurement Decisions with Health Technology Assessment and Multi-Criteria Decision Analysis.
Yang C; Wang Y; Hu X; Chen Y; Qian L; Li F; Gu W; Liu Q; Wang D; Chai X
Inquiry; 2021; 58():469580211022911. PubMed ID: 34120491
[TBL] [Abstract][Full Text] [Related]
38. Multiple criteria decision analysis for health technology assessment.
Thokala P; Duenas A
Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
[TBL] [Abstract][Full Text] [Related]
39. Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe.
Vončina L; Strbad T; Fürst J; Dimitrova M; Kamusheva M; Vila M; Mardare I; Hristova K; Harsanyi A; Atanasijević D; Banović I; Bobinac A
Appl Health Econ Health Policy; 2021 Nov; 19(6):915-927. PubMed ID: 34553334
[TBL] [Abstract][Full Text] [Related]
40. From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries.
Panteli D; Eckhardt H; Nolting A; Busse R; Kulig M
Health Res Policy Syst; 2015 Sep; 13():39. PubMed ID: 26407728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
